The incidence of urosepsis was 1.1% (12/1090) with CIP alone, which was reduced to 0.2% (2/1197) with CIP-FOS combination therapy (Morin et al., 2020). The gene discussed is FOS; the disease is hereditary sensory and autonomic neuropathy.